Major clinical research advances in gynecologic cancer 2008.
10.3802/jgo.2008.19.4.209
- Author:
Kidong KIM
1
;
Seok Cheol CHOI
;
Sang Young RYU
;
Jae Weon KIM
;
Soon Beom KANG
Author Information
1. Department of Obstetrics and Gynecology, Korea Cancer Center Hospital, Korea Institute of Radiological & Medical Sciences, Korea.
- Publication Type:Review
- Keywords:
Gynecology;
Urogenital neoplasms;
Biomedical research
- MeSH:
Biomarkers;
Female;
Gynecology;
Humans;
Leiomyosarcoma;
Lymph Node Excision;
Mass Screening;
Nitriles;
Ovarian Neoplasms;
Pyrethrins;
Radiotherapy, Adjuvant;
Trophoblastic Neoplasms;
Urogenital Neoplasms;
Uterine Cervical Neoplasms;
Uterine Neoplasms;
Vulvar Neoplasms
- From:Journal of Gynecologic Oncology
2008;19(4):209-217
- CountryRepublic of Korea
- Language:English
-
Abstract:
In this review, we summarized 14 major clinical advances in gynecology which occurred in 2008. For cervical cancer, clinical impact of HPV vaccine, prognostic value of imaging during radiotherapy, and oncologic/obstetric outcomes of fertility-sparing surgery were chosen. For uterine cancer, optimal method of adjuvant radiotherapy in intermediate-risk patients, extent of lymph node dissection, outcome of robot-assisted staging surgery, new standard chemotherapy regimen for leiomyosarcoma were selected. For ovarian cancer, recent changes in adjuvant therapy, feasibility of neoadjuvant chemotherapy, prediction of optimal secondary cytoreduction, studies on new biomarkers, advances in screening and treatment of women with BRCA mutations were included. For other cancers, the safety of sentinel lymph node dissection in vulvar cancer and chemotherapy regimens for low-risk gestational trophoblastic tumors were reviewed.
